# Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients

> **NCT01046045** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 17 (actual)

## Conditions studied

- Chronic Allograft Dysfunction in Renal Transplantation

## Interventions

- **DRUG:** everolimus

## Key facts

- **NCT ID:** NCT01046045
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-11
- **Final completion:** 2013-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046045, "Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01046045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*